Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 105,952,381 | reported | 18 Mar 2019 | tx 2+16,666,667 |
| Urovant Sciences Ltd. | 22,841,809 | reported | 14 Jun 2019 | tx 17+102,533 |
| ANADYS PHARMACEUTICALS INC | 11,420,654 | reported | 03 Jan 2011 | tx 16+2,808,823 |
| ACHILLION PHARMACEUTICALS INC | 10,037,553 | reported | 16 Jun 2014 | tx 36+2,605,757−5,599,100 |
| INHIBITEX, INC. | 7,934,562 | reported | 31 May 2011 | tx 24+677,828−655,000 |
| MEDIVATION, INC. | 3,391,784 | reported | 07 Jun 2011 | tx 28+458,515−636,902 |
| Pharmasset Inc | 2,793,274 | reported | 24 Sept 2009 | tx 4−910,000 |
| TPC Group Inc. | 2,719,145 | reported | 28 Dec 2010 | tx 3+194,490−73,600 |
| Arbutus Biopharma Corp | 1,164,000 | reported | 12 Jan 2018 | tx 2+1,164,000 |
| CONCERT PHARMACEUTICALS, INC. | 559,999 | reported | 19 Feb 2014 | tx 5+559,999−1,469,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,500 | 8.30 USD | |
| 13 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,367 | 7.95 USD | |
| 14 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,144 | 7.91 USD | |
| 11 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,189 | 8.58 USD | |
| 10 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,500 | 8.35 USD | |
| 07 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 6,649 | 7.97 USD | |
| 30 May 2019 | PURCHASE | Urovant Sciences Ltd. | 6,951 | 7.97 USD | |
| 30 May 2019 | PURCHASE | Urovant Sciences Ltd. | 300 | 8.91 USD | |
| 31 May 2019 | PURCHASE | Urovant Sciences Ltd. | 5,071 | 7.70 USD | |
| 03 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 5,424 | 7.71 USD | |
| 23 May 2019 | PURCHASE | Urovant Sciences Ltd. | 4,802 | 7.76 USD | |
| 21 May 2019 | PURCHASE | Urovant Sciences Ltd. | 9,995 | 8.52 USD | |
| 22 May 2019 | PURCHASE | Urovant Sciences Ltd. | 5,033 | 8.06 USD | |
| 20 May 2019 | PURCHASE | Urovant Sciences Ltd. | 1,715 | 8.39 USD | |
| 16 May 2019 | PURCHASE | Urovant Sciences Ltd. | 5,408 | 6.79 USD | |
| 17 May 2019 | PURCHASE | Urovant Sciences Ltd. | 6,200 | 7.36 USD | |
| 20 May 2019 | PURCHASE | Urovant Sciences Ltd. | 8,285 | 7.98 USD | |
| 18 Mar 2019 | PURCHASE | Axovant Sciences Ltd. | 6,666,667 | 1.50 USD | |
| 18 Dec 2018 | PURCHASE | Axovant Sciences Ltd. | 10,000,000 | 1.00 USD | |
| 12 Jan 2018 | PURCHASE | Arbutus Biopharma Corp | 664,000 | 100.00 USD | derivanomaly |
| 16 Oct 2017 | PURCHASE | Arbutus Biopharma Corp | 500,000 | 100.00 USD | derivfirst after silenceanomaly |
| 16 Jun 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 224,400 | 7.79 USD | |
| 16 Jun 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 100,000 | 7.85 USD | |
| 16 Jun 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 944,400 | 7.71 USD | |
| 16 Jun 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 150,000 | 7.81 USD |
2 purchases reported after at least 12 months of silence — most recent on 16 Oct 2017.